Results 211 to 220 of about 1,060,633 (312)

Accurate prediction of drug-target interactions in Chinese and western medicine by the CWI-DTI model. [PDF]

Sci Rep
Li Y, Zhang X, Chen Z, Yang H, Liu Y, Wang H, Yan T, Xiang J, Wang B.   +8 more
europepmc   +1 more source

Enhancing the Pharmacokinetics of Aptamers: Targeting AXL In Vivo Using a Bottlebrush Polymer‐Conjugated Aptamer

Advanced Healthcare Materials, EarlyView.
A phosphodiester‐backboned bottlebrush polymer (pacDNA) engineered for aptamer delivery is presented. This design enhances aptamer stability, plasma pharmacokinetics, and target engagement in vivo. In AXL‐driven cancer models, pacDNA inhibits AXL signaling and reduces tumor growth, highlighting the promise of precision polymer scaffolds in aptamer ...
Tingyu Sun, Jiachen Lin, Chenyang Xue, Yuyan Wang, Peiru Chen, Yun Wei, Guobin Xu, Anais Sidonia, Chris Nenopoulos, Hossam Tashkandi, Caroline Shen, Allison Wang, Alex Wang, Ke Zhang   +13 more
wiley   +1 more source

Advances in the multimodal management of perioperative hypothermia: approaches from traditional Chinese and Western medicine. [PDF]

Perioper Med (Lond)
Zhang B, Zhou H, Wang X, Zheng Y, Hu L.
europepmc   +1 more source

RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy

Advanced Healthcare Materials, EarlyView.
An RBC membrane camouflaged, cell‐penetrating peptides R8‐based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), inducing tumor cell apoptosis, reducing tumor metastasis invasion and triggering autophagy disorder in breast cancer and liver cancer.
Qian Cheng, Xuemei Zhong, Lu Deng, Xinling He, Miaoxizi Luo, Ruibing Wang, Jinming Zhang   +6 more
wiley   +1 more source

An Integrative Path Model of Healthcare Utilization Determinants in Traditional Korean Medicine and Western Medicine Based on the Anderson Behavioral Model. [PDF]

Healthcare (Basel)
Park M.
europepmc   +1 more source

Survey of the Use of Kampo Medicines at Kampo Clinic I-Combined Use with Western Drugs-

, 2007
Nobutomo Ikarashi, Ayaka Shimura, T Takezawa, Asami Muto, Takahiro Toda, Kiyomi Ito, Takayoshi Kimura, Tetsuo AKIBA, Yoshifumi Irie, Kako Watanabe, Motoko FUKUZAWA, Hirokazu Ishii, Kenji Watanabe, Kiyoshi Sugiyama   +13 more
openalex   +2 more sources

Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response

Advanced Healthcare Materials, EarlyView.
In this paper, a novel nanoparticle scaffold composed of dendrimers conjugated with peptide‐based immune checkpoint inhibitors, enhancing drug delivery efficacy is introduced. By conjugating PD‐L1‐binding peptides to dendrimers, multivalent binding effects are harnessed, resulting in enhanced binding affinity, prolonged half‐life, and improved ...
DaWon Kim, Jin Woong Lee, Piper A. Rawding, Mari Iida, Carter Kim, Kourtney L. Kostecki, Michael J. Poellmann, Bridget Crossman, Ashley S. Liu, YoungSoo Kim, Deric L. Wheeler, Seungpyo Hong   +11 more
wiley   +1 more source

Efficacy and safety of Tripterygium wilfordii glycosides tablets combined with Western medicine for patients with rheumatic immune diseases.

World J Clin Cases
Shu H, Chen XY, Zhao J, Li P, Sun Z.
europepmc   +1 more source

Astragalus-containing Chinese herbal medicine used with Western medicine for lupus nephritis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Li J, Wu M, Liu W.
europepmc   +1 more source